MedTrace Logo

Predictors of Outcome and Natural History in Patients With Cervical Spondylotic Myelopathy

NCT02936245 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2016-10-18

No results posted yet for this study

Summary

Cervical spondylotic myelopathy (CSM) is the most frequent cause of myelopathy in those over the age of 50. They claim that surgical treatment of myelopathy, especially of the mild and moderate forms, has not shown better results than conservative treatment in the long term, and criteria for the indication and the timing of the operation have not been established. In order to get some more reliable data, a long-term follow up observational study will be started to confirm the effects of long term for conservative treatment.

Conditions

  • Cervical Spondylosis With Myelopathy

Interventions

OTHER

no specific intervention

We will not assign specific intervention in this research. We will record their baseline characteristics, received treatment, and assess the outcomes to analysis the predictors of outcome and natural history in patients with cervical spondylotic myelopathy.

Sponsors & Collaborators

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Wang Yongjun, PhD · Longhua Hospital, Shanghai Universiy of Traditional Chinese Medicine

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2019-12-31
Completion
2020-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02936245 on ClinicalTrials.gov